This trial is active, not recruiting.

Conditions eosinophilic gastrointestinal disorders (egid), eosinophilic esophagitis, eosinophilic disorder
Sponsor Children's Hospital Medical Center, Cincinnati
Collaborator National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Start date November 2012
End date December 2050
Trial size 10000 participants
Trial identifier NCT01382563, 2010-1579


Develop Registry tool

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model case-only

Primary Outcomes

Registry Aim
time frame: Open-ended

Eligibility Criteria

Male or female participants from 1 year up to 12 years old.

Inclusion Criteria: - Eosinophilic Gastrointestinal Disorder diagnosis

Additional Information

Official title Registry for Eosinophilic Gastrointestinal Disorders (REGID)
Principal investigator Marc E. Rothenberg, MD, PhD
Description The purpose of this research study is to develop a registry tool used for the management and care of patients with eosinophilic disorders, and create a research resource that will provide further insights into these disorders.
Trial information was received from ClinicalTrials.gov and was last updated in August 2016.
Information provided to ClinicalTrials.gov by Children's Hospital Medical Center, Cincinnati.